GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes

GLP-1s have become the world's most discussed drugs for their dramatic effects on weight-loss. Here David Morris discusses their original use and efficacy for patients with type 2 diabetes

Authors

Institutions

Publication Details

Journal
Independent Nurse
Published
2025-10-02
DOI
https://doi.org/10.12968/indn.2025.10.24
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes

David L. Morris
Independent Nurse
Diabetes Treatment and Management
article

GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes

David L. Morris
article en

Abstract

GLP-1s have become the world's most discussed drugs for their dramatic effects on weight-loss. Here David Morris discusses their original use and efficacy for patients with type 2 diabetes

Independent NurseVol. 2025(10)
Diabetes Australia (AU)
Openalex Percentile: Top 53%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1 and GIP/GLP-1 receptor agonists for type 2 diabetes — David L. Morris · Independent Nurse (2025) | TGRS Research Map | TGRS